Platelet Rich Plasma Following Hysteroscopic Adhesolysis
NCT ID: NCT03881215
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2016-01-01
2020-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions
NCT03541746
Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome
NCT04308811
Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing
NCT03497325
Permanent Occlusion of Uteine Arteies in Management of Abnormal Uterine Bleeding
NCT05423067
Platelet-rich Plasma Use as Prophylactic of Low Back Pain Post-spinal Following Gynecological Surgery
NCT02970058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platelet Rich Plasma
PRP
Platelet Rich Plasma
Platelet Rich Plasma
intra-uterine balloon
intra-uterine balloon
intra-uterine balloon
intra-uterine balloon
intra-uterine balloon
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet Rich Plasma
Platelet Rich Plasma
intra-uterine balloon
intra-uterine balloon
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Grade III intra-uterine adhesions
Exclusion Criteria
* Hb \< 11 g/dL, platelets \< 150.000/mm3.
* Patient taking anticoagulant.
* Patient taking NSAID in the 10 days before procedure.
* Any significant comorbidity or psychiatric disorder that would compromise patient's consent.
* Active cervical or uterine infection.
* Undiagnosed genital bleeding.
* pregnancy.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed S Sweed, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS1811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.